Who uses a prescription drug monitoring program and how? Insights from a statewide survey of Oregon clinicians
- PMID: 24787089
- PMCID: PMC4079731
- DOI: 10.1016/j.jpain.2014.04.003
Who uses a prescription drug monitoring program and how? Insights from a statewide survey of Oregon clinicians
Abstract
Prescription drug monitoring programs (PDMPs) are relatively new but potentially useful tools to enhance prudent prescribing of controlled substances. However, little is known about the types of clinicians who make the most use of PDMPs, how these programs are incorporated into clinicians' work flow, or how clinicians and patients respond to the information. We therefore surveyed a random sample of Oregon providers, with 1,065 respondents. Clinicians in emergency medicine, primary care, and pain and addiction specialties were the largest number of registrants, but many frequent prescribers of controlled substances were not registered to use the PDMP. Among users, 95% reported accessing the PDMP when they suspected a patient of abuse or diversion, but fewer than half would check it for every new patient or every time they prescribe a controlled drug. Nearly all PDMP users reported that they discuss worrisome PDMP data with patients; 54% reported making mental health or substance abuse referrals, and 36% reported sometimes discharging patients from the practice. Clinicians reported frequent patient denial or anger and only occasional requests for help with drug dependence. More research is needed to optimize how clinicians use PDMPs across settings and how clinicians and patients respond to the data.
Perspective: This study examined differences between PDMP users and nonusers and how clinicians in various specialties use PDMPs in practice. A better understanding of effective PDMP use will facilitate access to treatment for patients with pain while curbing the prescription drug epidemic and may ultimately reduce abuse, misuse, and overdose death.
Keywords: Prescription drug monitoring program; controlled substances; opioid prescribing; prescription drug abuse; survey.
Copyright © 2014 American Pain Society. Published by Elsevier Inc. All rights reserved.
Figures
Similar articles
-
Association of Prescription Drug Monitoring Program Use With Opioid Prescribing and Health Outcomes: A Comparison of Program Users and Nonusers.J Pain. 2018 Feb;19(2):166-177. doi: 10.1016/j.jpain.2017.10.001. Epub 2017 Oct 18. J Pain. 2018. PMID: 29054493 Free PMC article.
-
Physician attitudes and experiences with Maryland's prescription drug monitoring program (PDMP).Addiction. 2017 Feb;112(2):311-319. doi: 10.1111/add.13620. Epub 2016 Nov 3. Addiction. 2017. PMID: 27658522
-
Opioid Prescribing Patterns and Patient Outcomes by Prescriber Type in the Oregon Prescription Drug Monitoring Program.Pain Med. 2018 Dec 1;19(12):2481-2486. doi: 10.1093/pm/pnx283. Pain Med. 2018. PMID: 29155988 Free PMC article.
-
How prescription drug monitoring programs influence clinical decision-making: A mixed methods systematic review and meta-analysis.Drug Alcohol Depend. 2021 Nov 1;228:109090. doi: 10.1016/j.drugalcdep.2021.109090. Epub 2021 Sep 22. Drug Alcohol Depend. 2021. PMID: 34600255 Review.
-
Prescription drug monitoring programs, a response to doctor shopping: purpose, effectiveness, and directions for future research.Issues Ment Health Nurs. 2012 May;33(5):319-28. doi: 10.3109/01612840.2011.654046. Issues Ment Health Nurs. 2012. PMID: 22545639 Review.
Cited by
-
Efficacy of interventions targeted at physician prescribers of opioids for chronic non-cancer pain: an overview of systematic reviews.BMC Med. 2024 Feb 20;22(1):76. doi: 10.1186/s12916-024-03287-1. BMC Med. 2024. PMID: 38378544 Free PMC article. Review.
-
A Review of Federal and Statewide Guidelines and Their Effects on Orthopedics.Cureus. 2023 Sep 16;15(9):e45374. doi: 10.7759/cureus.45374. eCollection 2023 Sep. Cureus. 2023. PMID: 37849581 Free PMC article. Review.
-
CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022.MMWR Recomm Rep. 2022 Nov 4;71(3):1-95. doi: 10.15585/mmwr.rr7103a1. MMWR Recomm Rep. 2022. PMID: 36327391 Free PMC article.
-
Health Care Provider Utilization of Prescription Monitoring Programs: A Systematic Review and Meta-Analysis.Pain Med. 2021 Jul 25;22(7):1570-1582. doi: 10.1093/pm/pnaa412. Pain Med. 2021. PMID: 33484144 Free PMC article.
-
A comparison of trends in opioid dispensing patterns between Medicaid pharmacy claims and prescription drug monitoring program data.Pharmacoepidemiol Drug Saf. 2020 Sep;29(9):1168-1174. doi: 10.1002/pds.5097. Epub 2020 Aug 10. Pharmacoepidemiol Drug Saf. 2020. PMID: 32939909 Free PMC article.
References
-
- Asch DA, Jedrziewski MK, Christakis NA. Response Rates to Mail Surveys Published in Medical Journals. J Clin Epidmiol. 1997;50(10):1129–1136. - PubMed
-
- Baehren DF, Marco CA, Droz DE, Sinha S, Callan EM, Akpunonu P. A Statewide Prescription Monitoring Program Affects Emergency Department Prescribing Behaviors. Ann Emerg Med. 2010;56(3):19–23. - PubMed
-
- Breuer B, Cruciani R, Portenoy RK. Pain Management by Primary Care Physicians Chiropractors, and Acupuncturists: A National Survey. Pain Physicians. 2010;103(8):738–747. - PubMed
-
- Dowler David. Early Assessment of the Prescription Drug Monitoring Program: A Survey of Providers: Program Design and Evaluation Services. Multnomah County Health Department and Oregon Health Authority. 2013 http://www.orpdmp.com/orpdmpfiles/PDF_Files/Reports/PDES_PDMPeval_01.10.....
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical